“Meds-in-Hand” Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis

Abstract
Pediatric human immunodeficiency virus post-exposure prophylaxis is frequently indicated, but delays in medication receipt are common. Using plan-do-study-act cycles, we developed a multidisciplinary collaboration to reduce critical process delays in our pediatric emergency department. Interruptions decreased from a median 1 per month pre-intervention to zero per month during the intervention.
Funding Information
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (5T32AI052074-12)
  • Committee of Interns and Residents, Patient Care Fund Grant, Boston Medical Center
  • Boston University (BU) Clinical and Translational Sciences Institute (1UL1TR001430)